Last week the U.S. Senate introduced bipartisan legislation which would provide patients better access to testing and treatment for common infections like respiratory syncytial virus, COVID-19, influenza, and strep throat. The bill would also make permanent authorities for pharmacy-based immunizations that were authorized under emergency action during the COVID-19 pandemic.